XL Lin

XL Lin is the Executive Director of Esco Lifesciences Group. He is also the Founder, CEO, and President of Esco Aster, an affiliated company providing certified cGMP-compliant CRDMO services.

XL has held a range of roles, from Sales & Marketing for life science tools and Singapore Local Sales/Service GM, to Market Development Director. In March 2009, he founded the Esco Healthcare division, where he led the development, design, and engineering of Esco’s first downflow booths and aseptic isolators with hydrogen peroxide bio-decontamination. He also led new product development and set the strategic roadmap, guiding the executive team across three regional headquarters serving global markets.

In June 2015, driven by the goal of vaccine self-sufficiency for Southeast Asia, he founded Esco Aster, a bioprocessing tools and services provider aimed at reducing vaccine costs for the developing world. Today, Esco Aster, powered by the patented Tide Motion Adherent Cell Platform, specializes in GMP scale-up services for cell and gene therapies, as well as cellular agriculture.

XL earned his B.Sc. from the University of Sydney, Australia.